NCT05700396View on ClinicalTrials.gov

Breast Cancer Survivor Educational Intervention

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Breast CancerBreast NeoplasmsBreast CarcinomaBreast Cancer Female
Interventions
BEHAVIORAL

Breast Cancer Survivor Education Program

Weekly sessions via Zoom platform with study staff.

Trial Locations (1)

02215

Massachusetts General Hospital Cancer Center, Boston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

collaborator

Pfizer

INDUSTRY

lead

Massachusetts General Hospital

OTHER